Adicet Bio (NASDAQ:ACET) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright restated their neutral rating on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a research report sent to investors on Thursday, Benzinga reports. Several other research firms have also recently issued reports on ACET. Canaccord Genuity Group decreased their price objective on shares of Adicet Bio from $19.00 to $8.00 and set […]
More Stories
Flaherty & Crumrine Preferred Securities Income Fund Inc. (NYSE:FFC) Raises Dividend to $0.09 Per Share
Flaherty & Crumrine Preferred Securities Income Fund Inc. (NYSE:FFC – Get Free Report) announced a monthly dividend on Monday, July...
Genesis Energy Limited (GNE) to Issue Final Dividend of $0.06 on October 10th
Genesis Energy Limited (ASX:GNE – Get Free Report) announced a final dividend on Thursday, September 19th, MarketIndexAU reports. Investors of...
Finsbury Growth & Income (FGT) To Go Ex-Dividend on October 3rd
Finsbury Growth & Income (LON:FGT – Get Free Report) declared a dividend on Friday, September 20th, Upcoming.Co.Uk reports. Shareholders of...
Tasmea Limited (TEA) to Issue Final Dividend of $0.04 on October 16th
Tasmea Limited (ASX:TEA – Get Free Report) announced a final dividend on Friday, September 20th, MarketIndexAU reports. Investors of record...
Galaxy Entertainment Group Limited (OTCMKTS:GXYEF) Announces Dividend of $0.50
Galaxy Entertainment Group Limited (OTCMKTS:GXYEF – Get Free Report) announced a dividend on Friday, September 20th, investing.com reports. Shareholders of...
United States Steel (NYSE:X) Updates Q3 2024 Earnings Guidance
United States Steel (NYSE:X – Get Free Report) updated its third quarter 2024 earnings guidance on Thursday. The company provided...